Neuromodulators for migraine prevention

Headache
Robert Kaniecki

Abstract

Migraine is a debilitating condition characterized by a cycle of painful headaches and headache-related symptoms interspersed with periods of worry, distress, and apprehension. The negative impact of migraine on patient functioning, workplace productivity, and other daily activities has been demonstrated through the use of a variety of clinician- and patient-reported assessment tools, including the Migraine-Specific Questionnaire and the Migraine Disability Assessment questionnaire. In addition to considering the frequency and severity of migraine, clinicians need to encourage more open dialogue with their patients about the impact of this disorder on daily activities and productivity. Only then can the most appropriate course of treatment be determined. Appropriately prescribed acute and preventive therapies should break the cycle of migraine and improve the daily activities of patients with this chronic condition. Divalproex sodium and topiramate are neuromodulators that are approved by the US Food and Drug Administration (FDA) for the prophylaxis (prevention) of migraine headache in adults. Non-FDA-approved neuromodulators sometimes used in the management of migraine headache include gabapentin, lamotrigine, levetiracetam, a...Continue Reading

References

Sep 1, 1979·Headache·P Stensrud, O Sjaastad
Jan 1, 1992·JAMA : the Journal of the American Medical Association·W F StewartM L Reed
Jun 24, 1972·The Medical Journal of Australia·M AnthonyB Somerville
Feb 1, 1995·Cephalalgia : an International Journal of Headache·C G Dahlöf, E Dimenäs
Mar 1, 1995·Archives of Neurology·N T MathewR L Deaton
Jul 1, 1994·The American Journal of the Medical Sciences·S B ZachariahG S Ross
Aug 1, 1996·Cephalalgia : an International Journal of Headache·N T MathewC Lucker
Apr 1, 1997·Cephalalgia : an International Journal of Headache·J Klapper
Apr 1, 1997·Cephalalgia : an International Journal of Headache·T J SteinerA W Yuen
Oct 6, 1997·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·R K LewisS E Connor
May 28, 1998·Cephalalgia : an International Journal of Headache·W M MullenersT J Steiner
Aug 19, 1999·Behaviour Research and Therapy·G J AsmundsonF Veloso
May 8, 2000·BMJ : British Medical Journal·C A BarryN Barber
Mar 17, 2001·Headache·N T MathewS Tepper
Jun 12, 2002·Neurology·Frederick G FreitagUNKNOWN Depakote ER Migraine Study Group
Nov 19, 2002·Annals of Internal Medicine·Vincenza SnowUNKNOWN American College of Physicians-American Society of Internal Medicine
Apr 12, 2003·Neurology·R B LiptonP J Goadsby
Jun 17, 2003·Cephalalgia : an International Journal of Headache·C WacogneC Le Jeunne
Dec 4, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Diane M Turner-BowkerMark Kosinski
Jan 14, 2004·Journal of the American Pharmacists Association : JAPhA·Kem P KruegerBruce A Berger
Jan 30, 2004·JAMA : the Journal of the American Medical Association·Mark C KruitLenore J Launer
Feb 26, 2004·JAMA : the Journal of the American Medical Association·Jan Lewis BrandesUNKNOWN MIGR-002 Study Group
Mar 20, 2004·Cephalalgia : an International Journal of Headache·D L StronksJ Passchier
Apr 21, 2004·Archives of Neurology·Stephen D SilbersteinUNKNOWN MIGR-001 Study Group
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David A FishbainRenee Steele-Rosomoff
Aug 19, 2004·Journal of Neurology·Hans-Christoph DienerUNKNOWN MIGR-003 Study Group
Oct 12, 2004·Neurologic Clinics·Stephen D Silberstein
Nov 18, 2004·Headache·Randolph W EvansDavid M Biondi
Dec 23, 2004·Clinical Neuropharmacology·Miles E DrakeArito D Armentbright
Apr 19, 2005·Headache·Elizabeth Loder, David Biondi
Apr 19, 2005·Headache·Jan Lewis Brandes
May 14, 2005·Current Opinion in Neurology·Ann I ScherRichard B Lipton
Jul 22, 2005·International Journal of Clinical Practice·G BussoneS Schwalen
Jan 18, 2006·Headache·Randolph W EvansRichard B Lipton
Mar 15, 2006·Expert Review of Neurotherapeutics·Marcelo E Bigal, Richard B Lipton
May 27, 2006·Stroke; a Journal of Cerebral Circulation·Maria A RoccaMassimo Filippi

❮ Previous
Next ❯

Citations

Sep 4, 2008·Current Pain and Headache Reports·Abouch V KrymchantowskiMarcelo E Bigal
Jul 2, 2010·The Neurologist·Juline BrysonRichard B Lipton
Jan 28, 2009·Cephalalgia : an International Journal of Headache·A FerrariA Bertolini
Sep 3, 2009·Cephalalgia : an International Journal of Headache·S D Silberstein
May 11, 2010·Drugs & Aging·Matthew S Robbins, Richard B Lipton
Sep 23, 2009·Expert Review of Neurotherapeutics·Chad A Whyte, Stewart J Tepper
Jul 16, 2011·Expert Opinion on Drug Metabolism & Toxicology·Anna FerrariEmilio Sternieri
Jan 27, 2010·Headache·Angel L GuerreroRosa Fernández
Sep 27, 2018·Journal of the American Geriatrics Society·Thomas BerkBrinder Vij

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Medical Research and Opinion
Stephen SilbersteinSteven J Greenberg
Handbook of Clinical Neurology
S Tepper
Cephalalgia : an International Journal of Headache
T J SteinerA W Yuen
Archives of Neurology
Stephen SilbersteinMIGR-001 Study Group
© 2021 Meta ULC. All rights reserved